AgomAb Therapeutics N.V. American Depositary Shares PEG Ratio

AgomAb Therapeutics N.V. American Depositary Shares's peg ratio stands at -18.77. That is below the Healthcare sector average of 11.64. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

AgomAb Therapeutics N.V. American Depositary Shares sits lower the Healthcare benchmark (11.64) with a PEG ratio of -18.77. That is roughly 261.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether -18.77 is attractive depends on AgomAb Therapeutics N.V. American Depositary Shares's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how AgomAb Therapeutics N.V. American Depositary Shares's PEG ratio evolved across reporting periods, while the comparison chart places AGMB next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. AgomAb Therapeutics N.V. American Depositary Shares's reading of -18.77 (sector avg 11.64) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.